BRCA2 and hypoparathyroidism-retardation-dysmorphism syndrome: Our SWATH-MS analysis confirmed the proteomic signature of HRD established by iTRAQ DDA analysis wherein a sub-network of BRCA1- or BRCA2-related proteins displayed co-expression patterns differentiating HRD from non-HRD patients (Zhang et al., 2016a).